Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects.
Mitsuhiro Kawakubo; Miyako Tanaka; Kozue Ochi; Akiko Watanabe; Marie Saka-Tanaka; Yohei Kanamori; Naoki Yoshioka; Satoko Yamashita; Moritaka Goto; Michiko Itoh; Ibuki Shirakawa; Sayaka Kanai; Hiromi Suzuki; Makoto Sawada; Ayaka Ito; Masatoshi Ishigami; Mitsuhiro Fujishiro; Hiroshi Arima; Yoshihiro Ogawa; Takayoshi Suganami
Scientific reports, 2020年01月22日, 査読有り